Cite

HARVARD Citation

    Heitmeier, S. et al. (2022). Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa. Journal of thrombosis and haemostasis. pp. 1400-1411. [Online]. 
  
Back to record